Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

PlexusDx vs TOM Weight Loss

PlexusDx
Graded #158

Higher grade

vs+1.4000000000000057
TOM Weight Loss
Graded #193

Lower grade

The verdict

PlexusDx takes it — 67.7/100 to 66.3/100, but only just.

PlexusDx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. PlexusDx (plexusdx.com) is a US GLP-1 telehealth platform offering compounded weight-loss medications with licensed providers in all 50 states. TOM Weight Loss is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePlexusDx +16
74
58
Dose & formulationPlexusDx +2
64
62
Clinical oversightTOM Weight Loss +16
74
90
Labs & monitoringTOM Weight Loss +3
52
55
FulfillmentPlexusDx +5
78
73
Contract termsEven
55
55
PlexusDx · left barTOM Weight Loss · right bar

The numbers

MetricPlexusDxTOM Weight Loss
WeighScore67.7/10066.3/100
GradeCC
Scorecard rank#158#193
Semaglutide$149/mo (starting dose, compounded)$199/mo (all doses, compounded)
Tirzepatide$249/mo (starting dose, compounded)$249/mo (all doses, compounded)
CoverageAll 50 states2 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
PlexusDx

Graded #158 · C

Strengths

  • Licensed providers available in all 50 states
  • Range of options including low-cost microdose GLP-1 from $129/mo
  • Optional Precision Peptide genetic panel adds a personalization angle
  • Independent clinician review via state-licensed telehealth platform
  • Compounded medications from state-licensed pharmacies

Where it loses points

  • Compounded medications only; no FDA-approved brand options
  • Specific compounding pharmacies not named
  • Genetic-panel upsell may not add clinical value for everyone
  • Tirzepatide pricing from $249/mo is higher than budget rivals
  • No insurance accepted
TOM Weight Loss

Graded #193 · C

Strengths

  • ABOM board-certified physician (Dr. Tran Le, NPI 1194212258, verified ACTIVE)
  • Solo-physician model — every patient sees Dr. Le directly
  • Flat-rate pricing — no dose escalation surcharge
  • LegitScript badge displayed
  • No FDA Warning Letters

Where it loses points

  • Limited geographic footprint — Texas and Utah only
  • No named compounding pharmacy partner disclosed
  • Compounded medications are not FDA-approved
  • Cash-pay only, no insurance

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard